COMMUNIQUÉS West-GlobeNewswire

Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit

21/10/2024 - 22:00

Presentations will summarize new preclinical data from brain-penetrant, pan-mutant B-Raf degrader program and recent clinical data from NX-5948 BTK degrader program Members of the Nurix management team also to [...]

Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

21/10/2024 - 21:58

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five [...]

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

21/10/2024 - 21:08

CARSON CITY, Nev., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

HealthEx Raises $14M led by General Catalyst to Empower Patients and Health Systems to do more with Health Data

21/10/2024 - 20:00

HealthEx’s AI-driven preference and consent platform simplifies patient experience, automates security and compliance for healthcare organizations, unlocking how data can be used for good SAN FRANCISCO, Oct. 21, 2024 ( [...]

Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days

21/10/2024 - 19:56

WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]

AAMI, GCEA Translate HTM Guide into Spanish, Chinese, More

21/10/2024 - 19:44

AAMI Benchmarking Guide Now Free in Four New Languages Arlington, Oct. 21, 2024 (GLOBE NEWSWIRE) -- A new resource is available for clinical engineers and healthcare technology management (HTM) professionals just in [...]

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

21/10/2024 - 19:04

ZUG, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with [...]

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

21/10/2024 - 18:00

PRESS RELEASE REGULATED INFORMATION 21 October 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 21 October 2024 – Sequana Medical NV (Euronext Brussels: [...]

Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details

21/10/2024 - 17:50

BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will [...]

Valneva to Present on Chikungunya at Several Leading Scientific Conferences

21/10/2024 - 17:45

Saint-Herblain (France), October 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today that members of its senior leadership team will present datasets on the world’s [...]

Valneva effectuera des présentations sur le chikungunya lors de différentes conférences scientifiques de premier plan

21/10/2024 - 17:45

Saint-Herblain (France), le 21 octobre 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd'hui que des membres de son équipe de direction présenteront des données [...]

BioPorto A/S Announces Changes to the US Commercial Organization

21/10/2024 - 17:15

October 21, 2024 News release BioPorto A/S Announces Changes to the US Commercial Organization COPENHAGEN, DENMARK and BOSTON, MA, USA, October 21, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH: [...]

Responsibility statement for first half year of 2024

21/10/2024 - 17:00

Please find attached the first half 2024 financial report including the Responsibility Statement. ***** For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 Alexander.karlsen@vistin.com This [...]

The Froedtert & MCW Health Network Engages Digital Platform to Roll Out Clinical Nutrition Program to Patients and Employees

21/10/2024 - 16:33

Integrating the Season Health clinical nutrition program into the Xealth digital health platform streamlines provider referral flow, increasing access and improving outcomes MILWAUKEE and SEATTLE, Oct. 21, 2024 (GLOBE [...]

PetVivo Engages Another Top Sales Manager, Cindy Gill, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

21/10/2024 - 15:45

MINNEAPOLIS, MN, Oct. 21, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Cindy Gill to the position [...]

The Ensign Group Announces Appointment of Mark Parkinson to the Board of Directors

21/10/2024 - 15:33

SAN JUAN CAPISTRANO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG or the “Company”), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing [...]

Innocan Pharma to Present at the 2024 ThinkEquity Conference

21/10/2024 - 15:30

HERZLIYA, Israel and CALGARY, Alberta, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal [...]

Le KFSHRC ouvre la voie aux diagnostics et aux interventions chirurgicales mini-invasives alimentés par l’IA

21/10/2024 - 15:25

RIYAD, Arabie saoudite, 21 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) poursuit sa contribution envers l’avancement des soins de santé grâce à des progrès majeurs en [...]

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA

21/10/2024 - 15:25

TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]